Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine Showers for S. aureus in PWID
NCT03940729Phase 4Completed
- Sponsor
- Lund University
- Start
- Dec 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of chlorhexidine + cymenol gel in Staphylococcus aureus infection, sponsored by Lund University. Primary endpoint: Infection frequency at 2 years. Started Dec 2016; status: completed.
02
Drugs
chlorhexidine + cymenol gel
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT03940729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03940729.